Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-up

The Washington University

Status: Completed

Conditions: Breast Cancer

Treatments: Other: The Survivor Stories Tablet

Study type: Interventional

Funder types: Other

Identifiers

NCT00929084

000799

Details and patient eligibility

About

The purpose of this study is to evaluate in a randomized controlled trail, an innovative cancer communication strategy to help African American breast cancer patients cope with a variety of challenges during and after treatment and to better adhere to recommended treatment guidelines and follow-up care.

Full description

Disparities in incidence and mortality between African Americans and Caucasians for a number of cancers have been well documented. This study builds on previous work in St. Louis to overcome barriers to access to breast screening, identifying and addressing factors associated with access to care once diagnosed, and factors contributing to delay in diagnosis and completion of therapy. African American breast cancer patients randomly assigned to the intervention arm of the trial will have access to the Survivor Stories Tablet, a tablet computer, on which they will browse an archive of 1-3 minute videotaped survivor stories about five topics: coping, relationships, experiences with the health care system, follow-up care, and quality of life (QOL) living with breast cancer. Patients will have the tablet for two weeks after enrollment in the study, and again at 6 and 12 months. Patients in the control arm will receive usual care.

Enrollment: 228 patients

Sex: Female

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• African American women
• First primary ductal carcinoma in situ (DCIS) or stages I, II, or III invasive breast cancer.

Exclusion criteria

• Prior DCIS or breast cancer diagnosis
• Stage IV or metastatic breast cancer
• Planned to receive a double mastectomy
• non-English speaking,
• Having known psychiatric or neurologic disorders
• Being cognitively impaired according to weighted error scores on the Orientation-Memory-Concentration Test
• Being unwilling or unable to give consent

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

228 participants in 2 patient groups

Survivor Stories Arm

Other group

Description:

Women in the Survivor Stories intervention arm will be given the Survivor Stories Tablet to take home for two weeks at three different time points over a two year period.

Treatment:

Other: The Survivor Stories Tablet

Control Arm

Other group

Description:

Women in the Control Arm will receive standard care.

Treatment:

Other: The Survivor Stories Tablet